Revelle Aesthetics Receives $30M in Growth Funding

Revelle Aesthetics, Inc., a Mountain View, CA-based provider of solutions to reduce cellulite, received a commitment of $30 million in growth capital.

Trinity Capital Inc. (NASDAQ: TRIN) provided the financing.

The company intends to use the funds to expand production capabilities and bolster the growth and expansion of its operations, enabling them to further penetrate the market, driving sales and support marketing initiatives to reach a wider customer base.

Led by Caroline Van Hove, President and CEO, Revelle Aesthetics has gained recognition in the market with its FDA-cleared device, Avéli, which is indicated for long-term reduction in the appearance of cellulite as supported by clinical data demonstrating treatment benefits through one year of observation.